Using the same database we also checked stage-wise involvement of CD133 in human lung adenocarcinoma and surprisingly the results indicated gradual increase of CD133 expression with disease progression of NSCLCs (Fig. S2A–E). The gene discussed is PROM1; the disease is lung adenocarcinoma.